Defragmenting Data for the Future of Pharma R&D

Innovation in pharma today means faster ‘time to insight’. However, trying to innovate with disconnected, fragmented data is slow, costly and frustrating—for both pharma companies and patients. Today’s data resides within disparate sources scattered across the organization and beyond. This data can only provide value when it’s integrated—meaningfully and securely linked, accessible, and resilient to new sources and unintended use cases.
Read more...

;